Form 4: Veraxa Biotech Holding Director Buys Shares
Insider Transaction (Form 4)
Oliver Rolf Baumann, a Director of Veraxa Biotech Holding AG, purchased 50,000 shares of common stock on August 27, 2026 for $1.50 per share.
Summary
- Open-market purchase: acquired 50,000 Ordinary Shares at $1.50 ($75,000) on August 27, 2026; holds 5,773,618 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $75,000, committing personal capital to the stock.
Insider Transactions
Oliver Rolf Baumann — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Open-market purchase | Ordinary Shares | 50,000 | $2 | $75.0K | 5,773,618 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Open-market purchase (50,000 shares) |
Keywords
insider transaction, Form 4, VRXA, Veraxa Biotech AG - Post de-SPAC, bullish, Oliver Rolf Baumann
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.